Results 191 to 200 of about 41,061 (224)
Some of the next articles are maybe not open access.
Journal of Infection and Chemotherapy, 2009
We report a 54-year-old male patient with an infection caused by linezolid-resistant methicillin-resistant Staphylococcus aureus (MRSA), isolated after long-term, repeated use of linezolid. Five MRSA strains isolated from our patient were preserved and submitted to bacteriological analysis.
Koichiro, Yoshida +7 more
openaire +2 more sources
We report a 54-year-old male patient with an infection caused by linezolid-resistant methicillin-resistant Staphylococcus aureus (MRSA), isolated after long-term, repeated use of linezolid. Five MRSA strains isolated from our patient were preserved and submitted to bacteriological analysis.
Koichiro, Yoshida +7 more
openaire +2 more sources
Linezolid in children with drug resistant tuberculosis
Infectious Diseases, 2018To the Editor,In a recent review of the present journal on drug resistance in tuberculosis (TB) therapy, preconditions for second line treatment with amikacin, kanamycin, capreomycin and fluoroquin...
Ira, Shah, Amit, Dey, Naman S, Shetty
openaire +2 more sources
Linezolid-Resistant Enterococci in Greece: Epidemiological Characteristics
Chemotherapy, 2011<i>Background:</i> 14 linezolid-resistant enterococci (6 <i>Enterococcus faecium</i> and 8 <i>Enterococcus faecalis</i>) collected during 2009 from patients hospitalized in intensive care units of different Greek hospitals were investigated.
Iris, Spiliopoulou +6 more
openaire +2 more sources
Pediatric Infectious Disease Journal, 2006
We report 2 sisters with hyper-IgE syndrome treated with daily suppressive dosages of linezolid (LZD) who developed LZD-resistant Staphylococcus aureus carrying the G2576T mutation in the 23S rRNA gene. Molecular typing suggested transmission of the resistant strain from one sister to the other. LZD-susceptible S. aureus was isolated 2 months after LZD
Susanne M, Roberts +5 more
openaire +2 more sources
We report 2 sisters with hyper-IgE syndrome treated with daily suppressive dosages of linezolid (LZD) who developed LZD-resistant Staphylococcus aureus carrying the G2576T mutation in the 23S rRNA gene. Molecular typing suggested transmission of the resistant strain from one sister to the other. LZD-susceptible S. aureus was isolated 2 months after LZD
Susanne M, Roberts +5 more
openaire +2 more sources
Diagnostic Microbiology and Infectious Disease, 2018
We assessed risk factors for and outcomes of linezolid-resistant vancomycin-resistant Enterococcus faecium (LRVREF) bacteremia over 7 years. Thirty-four LRVREF cases were matched to 68 linezolid-susceptible VREF controls. The odds of bacteremia with LRVREF increased by 7% for each additional day of prior linezolid exposure.
Tiffeny T, Smith +6 more
openaire +2 more sources
We assessed risk factors for and outcomes of linezolid-resistant vancomycin-resistant Enterococcus faecium (LRVREF) bacteremia over 7 years. Thirty-four LRVREF cases were matched to 68 linezolid-susceptible VREF controls. The odds of bacteremia with LRVREF increased by 7% for each additional day of prior linezolid exposure.
Tiffeny T, Smith +6 more
openaire +2 more sources
Linezolid for Drug-Resistant Tuberculosis
New England Journal of Medicine, 2022Guy, Thwaites, Nhung V, Nguyen
openaire +2 more sources
Nosocomial Spread of Linezolid-Resistant, Vancomycin-ResistantEnterococcus faecium
New England Journal of Medicine, 2002To the Editor: Vancomycin-resistant enterococci have become important nosocomial pathogens in the United States. Since November 1995, rectal swabs for surveillance for vancomycin-resistant enterococci have been collected twice weekly from adult patients admitted to the liver, kidney, and pancreas transplantation unit at our institution.1 Recently ...
Inmaculada A, Herrero +2 more
openaire +2 more sources
[Linezolid-resistant enterococci].
Klinicka mikrobiologie a infekcni lekarstviTo assess the occurrence of linezolid-resistant enterococci (E. faecalis and E. faecium) in patients hospitalized at the centers and clinics of the Institute for Clinical and Experimental Medicine (IKEM).For the period from 1. 1. 2017 to 31. 12. 2022, isolates of E. faecalis and E.
openaire +1 more source
Linezolid for multidrug-resistant tuberculosis
The Lancet Infectious Diseases, 2012Kwok-Chiu, Chang +2 more
openaire +2 more sources
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
New England Journal of Medicine, 2022Timothy D. McHugh, Conor D Tweed
exaly